Neuropathy progression in hereditary transthyretin amyloidosis (ATTRv) patients after liver transplantation
- 23 June 2023
- journal article
- letter
- Published by Taylor & Francis in Amyloid
- Vol. 30 (4) , 440-441
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantationAmerican Journal of Transplantation, 2022
- Hereditary transthyretin amyloidosis: a model of medical progress for a fatal diseaseNature Reviews Neurology, 2019
- One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril compositionJournal of Internal Medicine, 2017
- Liver Transplantation for Hereditary Transthyretin AmyloidosisTransplantation, 2015
- Progression of transthyretin amyloid neuropathy after liver transplantationNeurology, 2010